Paralytics


Neuromuscular-blocking agents also known as paralytics block neuromuscular transmission at neuromuscular junction, causing loss of motion of skeletal muscles. This is accomplished similarly by acting presynaptically through the inhibition of acetylcholine (ACh) synthesis and by acting postsynaptically at the acetylcholine receptors of the motor nerve end-plate. While a few medications act presynaptically, (for example, botulinum toxin and tetanus poison), those of current clinical significance work postsynaptically. Because the appropriate dose of neuromuscular-blocking medication may paralyze muscles required for breathing (i.e., the diaphragm), mechanical ventilation should to be provided to maintain adequate respiration.


    Related Conference of Paralytics

    January 26-27, 2026

    3rd Global Summit on Geriatrics & Aging

    Paris, France
    March 09-10, 2026

    9th World Congress on Surgeons

    Singapore City, Singapore
    March 09-10, 2026

    12th International Conference on Surgeons

    Singapore City, Singapore
    May 14-15, 2026

    6th World Congress on Surgery

    London, UK
    September 14-15, 2026

    12th European Otolaryngology-ENT Surgery Conference

    Rome, Italy

    Paralytics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in